What is Ehlers-Danlos syndrome type 5?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Ehlers-Danlos Syndrome Type 5?

Ehlers-Danlos syndrome (EDS) type 5 is an outdated classification term that is no longer used in current medical practice. The modern 2017 International Classification recognizes 13 distinct EDS subtypes based on genetic and clinical criteria, and the historical "type 5" designation does not correspond to any of these current subtypes 1.

Historical Context and Modern Classification

The Villefranche Nosology, published in 1998, delineated six EDS subtypes and was the standard classification system for two decades 1. However, this system has been superseded by the 2017 International Classification, which expanded recognition to 13 subtypes based on advances in molecular genetics and clinical understanding 1.

  • The old numerical classification system (types 1-11) has been replaced with descriptive names based on clinical and genetic features 1, 2
  • 19 different causative genes have now been identified across the EDS spectrum, mostly related to collagen synthesis and extracellular matrix components 3, 4
  • The current classification groups subtypes by pathogenetic mechanisms rather than arbitrary numbers 1

Current EDS Subtypes You Should Know

The hypermobile type is the most common, accounting for 80-90% of all EDS cases 3, 5. Key features include:

  • Joint hypermobility confirmed by Beighton scale scores: ≥6/9 points for prepubertal children, ≥5/9 for adults under 50, and ≥4/9 for adults over 50 5
  • Soft or velvety skin with normal or slightly increased extensibility 6
  • Chronic joint or limb pain, recurrent dislocations, and easy bruising 6
  • Aortic root dilation occurs in one-quarter to one-third of cases, though dissection risk without significant dilation is not thought to be elevated 6

The vascular type (formerly type IV) poses the greatest mortality risk due to spontaneous arterial and organ ruptures 3. This is the most critical subtype to identify for prognostic purposes.

Clinical Hallmarks Across All EDS Types

The defining triad includes 7:

  • Joint hypermobility with recurrent dislocations or subluxations
  • Skin hyperextensibility and tissue fragility (severity varies by subtype)
  • Tissue fragility affecting blood vessels, organs, and wound healing

Diagnostic Approach

Diagnosis of all EDS subtypes except hypermobile type requires molecular confirmation with identification of causative genetic variants 1. For hypermobile EDS, diagnosis remains clinical based on revised criteria that distinguish it from other joint hypermobility disorders 1.

  • Physical examination focusing on Beighton scale assessment, skin texture, and tissue fragility 6
  • Echocardiogram to evaluate for aortic root dilation (present in 25-33% of hypermobile and classic types) 6
  • Dilated eye exam to exclude Marfan syndrome 6
  • Genetic testing for suspected subtypes other than hypermobile type 1

Common Pitfall to Avoid

Do not use outdated numerical classifications when communicating about EDS. Using terms like "type 5" creates confusion and may lead to inappropriate management, as the historical numbering system does not align with current genetic and clinical understanding 1, 2. Always refer to EDS subtypes by their descriptive names (hypermobile, classical, vascular, etc.) based on the 2017 International Classification.

References

Research

The 2017 international classification of the Ehlers-Danlos syndromes.

American journal of medical genetics. Part C, Seminars in medical genetics, 2017

Research

[Ehlers-Danlos syndrome--diagnosis and subclassification].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2006

Guideline

Classification and Diagnosis of Ehlers-Danlos Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hypermobile Ehlers-Danlos Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A review of Ehlers-Danlos syndrome.

JAAPA : official journal of the American Academy of Physician Assistants, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.